NVIDIA
NVDA
Tesla
TSLA
Super Micro Computer
SMCI
4
Palantir
PLTR
5
Applovin
APP
US Stock MarketDetailed Quotes
SWTX SpringWorks Therapeutics
- 54.140
- +0.110+0.20%
Close Feb 26 16:00 ET
- 55.000
- +0.860+1.59%
Pre 05:04 ET
4.06BMarket Cap-15.56P/E (TTM)
55.890High54.120Low1.16MVolume54.890Open54.030Pre Close63.68MTurnover1.58%Turnover RatioLossP/E (Static)74.94MShares62.00052wk High8.43P/B3.99BFloat Cap28.21052wk Low--Dividend TTM73.69MShs Float96.480Historical High--Div YieldTTM3.28%Amplitude13.600Historical Low54.783Avg Price1Lot Size
About SpringWorks Therapeutics Company
Springworks Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the application of a medicine approach to acquiring, developing, and commercializing medicines. Its pipeline includes Nirogacestat, Mirdametinib, Brimarafenib, SW-682, and EGFR Inhibitor. The company was founded in August 2017 and is headquartered in Stamford, CT.
Company Profile
SymbolSWTX
Company NameSpringWorks Therapeutics
Listing DateSep 13, 2019
Issue Price18.00
Founded2017
CEOMr. Saqib Islam, J.D.
MarketNASDAQ
Employees368
Fiscal Year Ends12-31
Address100 Washington Boulevard
CityStamford
ProvinceConnecticut
CountryUnited States of America
Zip Code06902
Phone1-203-883-9490
Websitehttp://www.springworkstx.com
Company Executives
- Name
- Position
- Salary
- Saqib Islam, J.D.
- Director and Chief Executive Officer
- 18.35M
- Tai-An Lin
- Chief Scientific Officer
- --
- Michael P. Nofi
- Chief Accounting Officer
- --
- Francis I. Perier, Jr
- Chief Financial Officer
- 3.74M
- Dr. Badreddin Edris, PhD
- Chief Operating Officer
- 6.64M
- Daniel Pichl
- Chief People Officer
- --
- Dr. James Cassidy, M.D.,PhD
- Chief Medical Officer
- 4.31M
- Bhavesh Ashar, M.B.A.
- Chief Commercial Officer
- --
- Daniel S. Lynch, M.B.A.
- Chairman of the Board
- 545.14K
- Dr. Julie Hambleton, M.D.
- Independent Director
- 520.14K
- Dr. Freda C. Lewis-Hall,M.D.
- Independent Director
- 508.45K
- Alan Fuhrman
- Independent Director
- 520.14K
- Carlos Alban
- Independent Director
- 507.64K
- Dr. Martin W. Mackay, PhD
- Independent Director
- --
- Herschel S. Weinstein, J.D.
- General Counsel and Secretary
- --